Company profile: DropWorks
1.1 - Company Overview
Company description
- Provider of instrumentation and analytical techniques using novel continuous flow droplet nanoreactors, focused on digital PCR that delivers absolute nucleic acid quantification and ultra-high sensitivity through a simple, high-throughput, low-cost workflow, enabling multiplexed analysis without standard NB curves or pipeline replicates pipelines.
Products and services
- Digital PCR: DropWorks architects droplet-based assays delivering absolute quantification and ultra-high sensitivity with multiplexed analysis, simple workflow, no standard curves or technical replicates, offering high-throughput, low-cost performance versus qPCR
- Continuous Flow Droplet Nanoreactor Instrumentation: DropWorks engineers custom-engineered instruments employing novel continuous flow droplet nanoreactors to drive simple workflows and high-throughput digital PCR with lower cost than qPCR
- Analytical Techniques: DropWorks develops workflow-optimized analytical techniques leveraging continuous flow droplet nanoreactors to achieve absolute nucleic acid quantification, ultra-high sensitivity, and multiplexed analysis without standard curves or technical replicates
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to DropWorks
GenomeSmart
HQ: United States
Website
- Description: Provider of an AI-powered genetic risk assessment, education, and matching platform that uses machine learning to generate personalized reports based on a person's profile, matching them to the right type of genetic tests and providing relevant details to simplify understanding of genetic testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenomeSmart company profile →
Caribou Biosciences
HQ: United States
Website
- Description: Provider of CRISPR genome-editing technologies and allogeneic CAR-T cell therapies for oncology. Offers chRDNA to enhance precision and reduce off-target effects; off-the-shelf CAR-T therapies for hematologic malignancies and autoimmune diseases; and candidates CB-010 (anti-CD19 for B cell non-Hodgkin lymphoma), CB-011 (anti-BCMA for multiple myeloma), and CB-012 (anti-CLL-1 for acute myeloid leukemia).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caribou Biosciences company profile →
SoftGenetics
HQ: United States
Website
- Description: Provider of genetic analysis software for researchers and clinicians, including Mutation Surveyor for Sanger DNA variant detection with custom reporting and user management; NextGENe for NGS SNP/indel, structural variant and transcriptome analysis; Geneticist Assistant for NGS variant interpretation, tracking and coverage confirmation; GeneMarker/HTS/MTP for genotyping, forensic NGS and multiple template processing, compatible with major sequencing systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SoftGenetics company profile →
Megazyme
HQ: Ireland
Website
- Description: Provider of analytical enzymes, chromogenic substrates, high-purity polysaccharides and colourimetric oligosaccharides; assay kits including Rapid Integrated Total Dietary Fiber and Lactose Assay; and Food Safety Division dehydrated culture media and diagnostic tests for foodborne bacteria, natural toxins, genetic modifications and allergens, serving laboratories in food & beverages, biofuel, animal feed, wine & brewing, dairy and cereals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Megazyme company profile →
OncoDNA
HQ: Belgium
Website
- Description: Provider of precision medicine for cancer treatment, leveraging over 60 years’ expertise in medical diagnostics and extensive experience in DNA sequencing and diagnostic analyses in oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OncoDNA company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for DropWorks
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to DropWorks
2.2 - Growth funds investing in similar companies to DropWorks
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for DropWorks
4.2 - Public trading comparable groups for DropWorks
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →